FAES Farma SA - Product Pipeline Review - 2015

Published: May, 2015 | Pages: 27 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

FAES Farma SA - Product Pipeline Review - 2015

Summary

Global Markets Direct's, 'FAES Farma SA - Product Pipeline Review - 2015', provides an overview of the FAES Farma SA's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of FAES Farma SA's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of FAES Farma SA including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of FAES Farma SA's human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the FAES Farma SA's pipeline products

Reason to Buy

- Evaluate FAES Farma SA's strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of FAES Farma SA in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the FAES Farma SA's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of FAES Farma SA and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of FAES Farma SA
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope
- Explore the dormant and discontinued projects of FAES Farma SA and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues

 Table of Contents

Table of Contents 2
List of Tables 4
List of Figures 4
FAES Farma SA Snapshot 5
FAES Farma SA Overview 5
Key Information 5
Key Facts 5
FAES Farma SA - Research and Development Overview 6
Key Therapeutic Areas 6
FAES Farma SA - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
FAES Farma SA - Pipeline Products Glance 10
FAES Farma SA - Late Stage Pipeline Products 10
Phase III Products/Combination Treatment Modalities 10
FAES Farma SA - Early Stage Pipeline Products 11
Preclinical Products/Combination Treatment Modalities 11
FAES Farma SA - Drug Profiles 12
bilastine 12
Product Description 12
Mechanism of Action 12
R&D Progress 12
Drugs for Dermatitis 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
Drugs for Immunology 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
F-10503LO1 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
F-98214TA 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
FAES Farma SA - Pipeline Analysis 18
FAES Farma SA - Pipeline Products by Target 18
FAES Farma SA - Pipeline Products by Route of Administration 19
FAES Farma SA - Pipeline Products by Molecule Type 20
FAES Farma SA - Pipeline Products by Mechanism of Action 21
FAES Farma SA - Recent Pipeline Updates 22
FAES Farma SA - Dormant Projects 23
FAES Farma SA - Company Statement 24
FAES Farma SA - Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Appendix 26
Methodology 26
Coverage 26
Secondary Research 26
Primary Research 26
Expert Panel Validation 26
Contact Us 26
Disclaimer 27

List of Tables

FAES Farma SA, Key Information 5
FAES Farma SA, Key Facts 5
FAES Farma SA - Pipeline by Indication, 2015 7
FAES Farma SA - Pipeline by Stage of Development, 2015 8
FAES Farma SA - Monotherapy Products in Pipeline, 2015 9
FAES Farma SA - Phase III, 2015 10
FAES Farma SA - Preclinical, 2015 11
FAES Farma SA - Pipeline by Target, 2015 18
FAES Farma SA - Pipeline by Route of Administration, 2015 19
FAES Farma SA - Pipeline by Molecule Type, 2015 20
FAES Farma SA - Pipeline Products by Mechanism of Action, 2015 21
FAES Farma SA - Recent Pipeline Updates, 2015 22
FAES Farma SA - Dormant Developmental Projects,2015 23
FAES Farma SA, Other Locations 25
FAES Farma SA, Subsidiaries 25